Inhibition of the multiplication of Mycobacterium leprae by vaccination with a recombinant M. bovis BCG strain that secretes major membrane protein II in mice

Clinical and Vaccine Immunology

Volumn 16, Issue 10, 2009, Pages 1399-1404

  Maeda, Y ^a   Tamura, T ^a   Matsuoka, M ^a   Makino, M ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BCG VACCINE; GAMMA INTERFERON; MAJOR MEMBRANE PROTEIN II; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BCG VACCINATION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOOT PAD; IMMUNOSTIMULATION; LEPROSY; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BCG VACCINE; HUMANS; LEPROSY; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MYCOBACTERIUM LEPRAE; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 70349695687     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00203-09     Document Type: Article

References (26)

1. Cho, S. N., and P. J. Brennan. 1999. New biological tools for leprosy surveillance. Int. J. Lepr. Other Mycobact. Dis. 67:59-62.
2. Convit, J., C. Sampson, M. Zúñiga, P. G. Smith, J. Plata, J. Silva, J. Molina, M. E. Pinardi, B. R. Bloom, and A. Salgado. 1992. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet 339:446-450.
3. Gelber, R. H., V. Mehra, B. Bloom, L. P. Murray, P. Siu, M. Tsang, and P. J. Brennan. 1994. Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads. Infect. Immun. 62:4250-4255.
4. Gormus, B. J., G. B. Baskin, K. Xu, M. S. Ratterree, L. N. Martin, P. A. Mack, R. P. Bohm, Jr., W. M. Meyers, and G. P. Walsh. 2000. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations. Int. J. Lepr. Other Mycobact. Dis. 68:434-443.
5. Hesseling, A. C., M. F. Cotton, C. Fordham von Reyn, S. M. Graham, R. P. Gie, and G. D. Hussey. 2008. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Int. J. Tuberc. Lung Dis. 12:1376-1379.
6. Hesseling, A. C., B. J. Marais, R. P. Gie, H. S. Schaaf, P. E. Fine, P. Godfrey-Faussett, and N. Beyers. 2007. The risk of disseminated bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 25: 14-18.
7. Karonga Prevention Trial Group. 1996. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 348:17-24.
8. Maeda, Y., T. Mukai, J. Spencer, and M. Makino. 2005. Identification of an immunomodulating agent from Mycobacterium leprae. Infect. Immun. 73: 2744-2750.
9. Makino, M., Y. Maeda, and K. Inagaki. 2006. Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae. Infect. Immun. 74:6264-6271.
10. McDermott-Lancaster, R. D., T. Ito, K. Kohsaka, C. C. Guelpa-Lauras, and J. H. Grosset. 1987. Multiplication of Mycobacterium leprae in the nude mouse, and some applications of nude mice to experimental leprosy. Int. J. Lepr. Other Mycobact. Dis. 55:889-895.
11. Modlin, R. L. 1994. Th1-Th2 paradigm: insights from leprosy. J. Investig. Dermatol. 102:828-832.
12. Nakamura, M. 1994. Elimination of contaminants in a homogenate of nudemouse footpad experimentally infected with Mycobacterium leprae. Jpn. J. Lepr. 64:47-50.
13. Ngamying, M., P. Sawanpanyalert, R. Butraporn, J. Nikasri, S. N. Cho, L. Levy, and P. J. Brennan. 2003. Effect of vaccination with refined components of the organism on infection of mice with Mycobacterium leprae. Infect. Immun. 71:1596-1598.
14. Nomaguchi, H., T. Mukai, F. Takeshita, M. Matsuoka, Y. Maeda, T. M. Aye, N. Jahan, Y. Yogi, M. Endo, Y. Sato, and M. Makino. 2002. Effect of hsp65 DNA vaccination carrying immunostimulatory DNA sequences (CpG motifs) against Mycobacterium leprae multiplication in mice. Int. J. Lepr. Other Mycobact. Dis. 70:182-190.
15. Ohara, N., M. Matsuoka, H. Nomaguchi, M. Naito, and T. Yamada. 2001. Protective responses against experimental Mycobacterium leprae infection in mice induced by recombinant bacillus Calmette-Guérin over-producing three putative protective antigen candidates. Vaccine 19:1906-1910.
16. + cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man. J. Exp. Med. 171:2011-2024.
17. Pönnighaus, J. M., P. E. Fine, J. A. Sterne, R. J. Wilson, E. Msosa, P. J. Gruer, P. A. Jenkins, S. B. Lucas, N. G. Liomba, and L. Bliss. 1992. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 339:636-639.
18. Salazar, L., H. Fsihi, E. de Rossi, G. Riccardi, C. Rios, S. T. Cole, and H. E. Takiff. 1996. Organization of the origins of replication of the chromosomes of Mycobacterium smegmatis, Mycobacterium leprae and Mycobacterium tuberculosis and isolation of a functional origin from M. smegmatis. Mol. Microbiol. 20:283-293.
19. Setia, M. S., C. Steinmaus, C. S. Ho, and G. W. Rutherford. 2006. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect. Dis. 6:162-170.
20. Sharma, P., R. Mukherjee, G. P. Talwar, K. G. Sarathchandra, R. Walia, S. K. Parida, R. M. Pandey, R. Rani, H. Kar, A. Mukherjee, K. Katoch, S. K. Benara, T. Singh, and P. Singh. 2005. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years. Lepr. Rev. 76:127-143.
21. Shepard, C. C., and D. H. McRae. 1968. A method for counting acid-fast bacteria. Int. J. Lepr. Other Mycobact. Dis. 36:78-82.
22. Shepard, C. C. 1983. Animal vaccination studies with Mycobacterium leprae. Int. J. Lepr. Other Mycobact. Dis. 51:519-523.
23. Trunz, B. B., P. Fine, and C. Dye. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367:1173-1180.
24. Walia, R., K. G. Sarathchandra, R. M. Pandey, S. K. Parida, S. A. Zaheer, H. K. Kar, A. Mukherjee, R. Mukherjee, and G. P. Talwar. 1993. Field trials on the use of Mycobacterium w vaccine in conjunction with multidrug therapy in leprosy patients for immunotherapeutic and immunoprophylactic purposes. Lepr. Rev. 64:302-311.
25. World Health Organization. 2008. Global leprosy situation, beginning of 2008. Wkly. Epidemiol. Rec. 33:293-300.
26. Zodpey, S. P. 2007. Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysis. Indian J. Dermatol. Venereol. Leprol. 73:86-93.